ASCEND helps you understand:
What biomarkers can help you validate your hypothesis?
Are there known risks to how effective your approach could be?
Is there evidence of toxic or harmful effects?
How can you reduce unnecessary trial and error?
Improve Visibility and Due Diligence
Review inventory, past purchases, and lab results to optimize resources, spending, and information sharing while reducing project redundancy.
Identify Critical Biomarkers
Discover pertinent biomarkers for prediction, prognosis, safety, and surrogate endpoints. Speed up assessment of biomarker feasibility by uncovering their underlying biological mechanisms and related methodologies.
Flag Obstacles Earlier
Assess risks to experiment strategy and research programs. Identify potential roadblocks towards clinical translation or support the need for alternative avenues.